InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

FATE THERAPEUTICS INC

FATE Clue Score25
United States Fiscal year ends December CIK 0001434316
$2.18 +2.35% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.18 −96.15% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue4.4Operating income−32.0Net income−33.5Fiscal year 2017Revenue4.1 −6.7%Operating income−42.1Net income−43.0Fiscal year 2018Revenue4.7 +15.4%Operating income−67.1Net income−66.6Fiscal year 2019Revenue10.7 +125.3%Operating income−100.7Net income−98.1Fiscal year 2020Revenue31.4 +194.3%Operating income−128.1Net income−173.4EPS, diluted−2.10Fiscal year 2021Revenue55.8 +77.7%Operating income−217.0Net income−212.2EPS, diluted−2.24Fiscal year 2022Revenue96.3 +72.4%Operating income−308.4Net income−281.7EPS, diluted−2.91Fiscal year 2023Revenue63.5 −34.0%Operating income−190.5Net income−160.9EPS, diluted−1.64Fiscal year 2024Revenue13.6 −78.5%Operating income−210.3Net income−186.3EPS, diluted−1.64Fiscal year 2025Revenue6.6 −51.2%Operating income−147.7Net income−136.3EPS, diluted−1.15
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 4.4 4.1 4.7 10.7 31.4 55.8 96.3 63.5 13.6 6.6
Growth −6.7% +15.4% +125.3% +194.3% +77.7% +72.4% −34.0% −78.5% −51.2%
Operating income −32.0 −42.1 −67.1 −100.7 −128.1 −217.0 −308.4 −190.5 −210.3 −147.7
Net income −33.5 −43.0 −66.6 −98.1 −173.4 −212.2 −281.7 −160.9 −186.3 −136.3
Growth
EPS, diluted n/a n/a n/a n/a −2.10 −2.24 −2.91 −1.64 −1.64 −1.15
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−726.1%Net margin−760.2%Free cash flow margin−687.9%Fiscal year 2017Operating margin−1,025.9%Net margin−1,046.1%Free cash flow margin−938.7%Fiscal year 2018Operating margin−1,415.4%Net margin−1,405.0%Free cash flow margin−864.0%Fiscal year 2019Operating margin−943.1%Net margin−919.0%Free cash flow margin−848.0%Fiscal year 2020Operating margin−407.5%Net margin−551.6%Free cash flow margin−140.5%Fiscal year 2021Operating margin−388.6%Net margin−379.9%Free cash flow margin−382.4%Fiscal year 2022Operating margin−320.2%Net margin−292.5%Free cash flow margin−294.7%Fiscal year 2023Operating margin−299.9%Net margin−253.3%Free cash flow margin−217.9%Fiscal year 2024Operating margin−1,542.6%Net margin−1,366.5%Free cash flow margin−906.8%Fiscal year 2025Operating margin−2,222.4%Net margin−2,051.1%Free cash flow margin−1,685.8%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −726.1% −1,025.9% −1,415.4% −943.1% −407.5% −388.6% −320.2% −299.9% −1,542.6% −2,222.4%
Net margin −760.2% −1,046.1% −1,405.0% −919.0% −551.6% −379.9% −292.5% −253.3% −1,366.5% −2,051.1%
Free cash flow margin −687.9% −938.7% −864.0% −848.0% −140.5% −382.4% −294.7% −217.9% −906.8% −1,685.8%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−29.8Capital expenditure−0.5Free cash flow−30.3Fiscal year 2017Operating cash flow−36.8Capital expenditure−1.7Free cash flow−38.5Fiscal year 2018Operating cash flow−38.7Capital expenditure−2.3Free cash flow−41.0Fiscal year 2019Operating cash flow−83.2Capital expenditure−7.4Free cash flow−90.6Fiscal year 2020Operating cash flow−39.2Capital expenditure−4.9Free cash flow−44.2Fiscal year 2021Operating cash flow−162.9Capital expenditure−50.7Free cash flow−213.6Fiscal year 2022Operating cash flow−248.2Capital expenditure−35.6Free cash flow−283.8Fiscal year 2023Operating cash flow−132.3Capital expenditure−6.2Free cash flow−138.4Fiscal year 2024Operating cash flow−122.9Capital expenditure−0.7Free cash flow−123.6Fiscal year 2025Operating cash flow−106.1Capital expenditure−6.0Free cash flow−112.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −29.8 −36.8 −38.7 −83.2 −39.2 −162.9 −248.2 −132.3 −122.9 −106.1
Capital expenditure −0.5 −1.7 −2.3 −7.4 −4.9 −50.7 −35.6 −6.2 −0.7 −6.0
Free cash flow −30.3 −38.5 −41.0 −90.6 −44.2 −213.6 −283.8 −138.4 −123.6 −112.0
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash88.6Total debt10.7Net cash (debt)77.9Shareholders’ equity73.2Debt to equity0.15Fiscal year 2017Cash89.0Total debt14.8Net cash (debt)74.1Shareholders’ equity77.2Debt to equity0.19Fiscal year 2018Cash190.5Total debt14.9Net cash (debt)175.6Shareholders’ equity160.5Debt to equity0.09Fiscal year 2019Cash99.8Shareholders’ equity244.8Fiscal year 2020Cash167.3Shareholders’ equity384.4Fiscal year 2021Cash133.6Shareholders’ equity678.8Fiscal year 2022Cash61.3Shareholders’ equity483.9Fiscal year 2023Cash41.9Shareholders’ equity368.4Fiscal year 2024Cash36.1Shareholders’ equity318.7Fiscal year 2025Cash46.6Shareholders’ equity207.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 88.6 89.0 190.5 99.8 167.3 133.6 61.3 41.9 36.1 46.6
Total debt 10.7 14.8 14.9 n/a n/a n/a n/a n/a n/a n/a
Net cash (debt) 77.9 74.1 175.6 n/a n/a n/a n/a n/a n/a n/a
Shareholders’ equity 73.2 77.2 160.5 244.8 384.4 678.8 483.9 368.4 318.7 207.2
Debt to equity 0.15 0.19 0.09 n/a n/a n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
4.4 4.1 4.7 10.7 31.4 55.8 96.3 63.5 13.6 6.6
Growth −6.7% +15.4% +125.3% +194.3% +77.7% +72.4% −34.0% −78.5% −51.2%
26.5 34.4 56.0 87.8 125.6 215.5 320.5 172.6 135.0 107.8
9.9 11.9 15.8 23.6 33.9 57.3 84.2 81.4 74.2 46.5
−32.0 −42.1 −67.1 −100.7 −128.1 −217.0 −308.4 −190.5 −210.3 −147.7
Growth
n/a n/a n/a 0.0 0.0 0.0 0.0 0.0 0.0 0.0
−33.5 −43.0 −66.6 −98.1 −173.4 −212.2 −281.7 −160.9 −186.3 −136.3
Growth
Per share
n/a n/a n/a n/a −2.10 −2.24 −2.91 −1.64 −1.64 −1.15
n/a n/a n/a n/a −2.10 −2.24 −2.91 −1.64 −1.64 −1.15
Growth
n/a n/a n/a n/a 82.4 94.7 96.8 98.4 113.7 118.8
n/a n/a n/a n/a 82.4 94.7 96.8 98.4 113.7 118.8
Growth +15.0% +2.2% +1.6% +15.5% +4.5%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 26.7% a year over five years.
  • The diluted share count rose 44.2% in five years, which is dilution.
  • Operating margin is down 1,815.0 points on five years ago, at -2,222.4%.
  • A net loss in 10 of 10 years on file.